(e) The OPERATING-SYSTEM for the patients at stages Ib1-Ib2 with large versus low B3GNT3 expression. B3GNT3expression was significantly upregulated in cervical cancer cell lines and lesions compared with normal cells and surrounding noncancerous cervical tissues. In the 196 cases of tested early-stage cervical cancer samples, the B3GNT3 protein level was positively correlated with high risk TYPES of human papillomavirus (HPV) contamination (P = 0. 026), FIGO stage (P < 0. 001), tumor size (P = 0. 025), tumor recurrence (P = 0. 004), vital status (P < 0. 001), concurrent chemotherapy and radiotherapy (P = 0. 016), lymphovascular space involvement (P = 0. 003) and most importantly, lymph node metastasis (P = 0. 003). Patients with high B3GNT3 expression had a shorter overall survival (OS) and disease-free survival (DFS) compared with those with low expression of this protein. Multivariate analysis suggested that B3GNT3 expression is an independent prognostic indicator for cervical cancer patients. == Conclusions == Our study demonstrated that elevated B3GNT3 expression is associated with pelvic lymph node metastasis and poor end result in early-stage cervical cancer patients. B3GNT3 may be a novel prognostic marker and therapeutic target for the treatment of cervical LY2801653 (Merestinib) cancer. == Intro == In women, cervical cancer is the third most commonly diagnosed malignant tumor from the reproductive tract worldwide, accounting for an estimated 274, 000 deaths globally annually [1]. Several studies possess indicated that high risk TYPES of human being papillomavirus (HPV) infection is a main risk for cervical development, but it remains unsatisfactory in diagnosis and predicting prognosis [2]. Advances in therapeutic methods and diagnostic tools possess decreased the incidence and mortality of cervical cancer [3]. However , it is still the major cause of gynecological oncology-related death in developing countries, especially patients with lymph node metastasis [4]. Moreover, lymph node metastasis is the strongest prognostic factor intended for Rabbit Polyclonal to ALS2CR13 early-stage cervical cancer (FIGO stage Ib-IIa) and it determines the treatment strategy for cervical cancer [5]. Modified expressions of oncogenes, such asBmi-1, URG4andC14ORF166[68], have been identified as potential prognostic markers in cervical cancer. However , the power of many identified biomarkers to predict lymph node metastasis and clinical end result of individual tumors is limited. Thus, the identification of novel and specific biomarkers for the early detection LY2801653 (Merestinib) and prediction of lymph node metastasis and prognosis in cervical cancer is important. The gene encoding 1, 3-N-acetylglucosaminyltransferase-3 (B3GNT3), formerly called core 13GlcNAcT, is located on chromosome 19q13. 1 and comprises three exons [9]. It is a member of the 3GlcNAcT family with a full-length mRNA of 2720 bp that encodes a highly conserved 43-kDa protein, which is classified as a type II transmembrane protein [10]. The 3GlcNAcT family comprises at least eight diverse 3GlcNAcTs that are associated with malignant transformation [11]. Downregulation of B3GNT1 is associated with poor end result in pancreatic ductal adenocarcinoma [12]. Etcheverry [13] found that B3GNT5 was overexpressed with a hypomethylated promoter in glioblastoma tissues compared with control brain LY2801653 (Merestinib) tissues. Shibata [14] proved that B3GNT7, which functions in the biosynthesis of the HMOCC-1 antigen, is expressed in higher in human ovarian cancer cells relative to normal ovaries. The level of B3GNT8 transcript was increased markedly and could be involved in malignancy in leukemia, laryngeal carcinoma, colon and gastric cancer [15, 16, 17, LY2801653 (Merestinib) 18]. B3GNT3 expression has been observed in normal tissue, including the colon, jejunum, stomach, esophagus, placenta and trachea [19]. Recently, Ho [20] reported that B3GNT3 might play an important role in suppressing the malignant phenotypes of neuroblastoma cells, including migration and invasion, by suppression of FAK, Akt and ERK, which are important.
